Erlonat 150 Mg Tablets

Erlonat 150 Mg Tablets Specification

Drug Type
General Medicines

Physical Form
Tablets

Dosage
150 Mg

Dosage Guidelines
As Per Suggestions

Storage Instructions
Dry Place

Erlonat 150 Mg Tablets Trade Information

Minimum Order Quantity
100 Bottles

Supply Ability
5000 Bottles Per Month

Delivery Time
7 Days

Main Export Market(s)
Asia, Australia, North America, Eastern Europe, Western Europe

About Erlonat 150 Mg Tablets

Discover unmatchable savings and exclusive access to Erlonat 150 Mg Tablets, the paragon solution for Non-Small Cell Lung Cancer and Pancreatic Cancer treatment. Sourced from India by a trusted exporter and wholesaler, Erlonat delivers unbeatable quality and efficacy with each fresh batch. Manufactured by Natco, each 150 mg tablet offers a reliable, prescription-based approach, ensuring you benefit from advanced pharmaceutical care. Experience the confidence of a superior general medicine, stored safely in a dry place, and enrich your wellness journey with genuine assurance.

Extra Features and Key Usages of Erlonat 150 Mg Tablets

Erlonat 150 Mg Tablets stand out for their fresh composition, precise 150 mg dosage, and reliability in critical cancer therapies. Crafted by Natco, the tablets are exclusively indicated for treating Non-Small Cell Lung Cancer and Pancreatic Cancer. Their application extends to oncology clinics and hospitals, ensuring patients access advanced cancer care. The tablets, supplied in a 30-tablet pack, are administered strictly as per expert guidelines, highlighting their premium pharmaceutical integrity and targeted therapeutic benefits.

Sample Availability, Export Facilities, and Domestic Reach

Erlonat 150 Mg Tablets are available with sample options, catering to both domestic and export markets. Connect via purchase order for a seamless procurement process. Our goods transport system efficiently operates from the appointed FOB port in India, ensuring timely deliveries. With a prominent presence in the main domestic markets and robust export channels, we prioritize secure and hassle-free distribution for every consignment, upholding global quality standards and reliability for our clients worldwide.

Specification

Strength	150 mg
Form	Tablet
Packaging Size	30 Tablets
Prescription/Non prescription	Prescription
Treatment	Non-Small Cell Lung Cancer and Pancreatic Cancer.
Manufacturer	Natco
Composition	Erlotinib
Brand	Erlonat

FAQ's of Erlonat 150 Mg Tablets:

Q: How should Erlonat 150 Mg Tablets be stored for optimal freshness?

A: Erlonat 150 Mg Tablets should be stored in a dry place, away from moisture and direct sunlight, to maintain their efficacy and shelf life.

Q: What areas of application are recommended for Erlonat 150 Mg Tablets?

A: This medication is primarily indicated for Non-Small Cell Lung Cancer and Pancreatic Cancer, and is commonly used in oncology clinics and hospitals under medical supervision.

Q: When is the best time to administer Erlonat 150 Mg Tablets?

A: Dosage and timing should strictly follow a healthcare provider's guidance. Patients should not self-medicate and must adhere to prescription instructions for optimal results.

Q: Where is Erlonat 150 Mg Tablets primarily distributed from?

A: The tablets are distributed from India, with both domestic and international reach, ensuring availability through exporters and wholesalers.

Q: What is the process for placing a purchase order for exports?

A: Interested buyers can initiate a purchase order, after which goods are shipped through the designated FOB port. All orders comply with export protocols to ensure safe and prompt delivery.

Q: What benefits do Erlonat 150 Mg Tablets offer over other general medicines?

A: Erlonat 150 Mg Tablets provide targeted, prescription-based therapy for serious cancers, supported by the reliability of Natco manufacturing and unmatchable export service.